Measure | Ever below | ≥ 2 h | ≥ 4 h | ≥ 8 h | ≥ 12 h | ≥ 16 h | ≥ 20 h |
---|---|---|---|---|---|---|---|
Continuous time below MAP threshold during vasopressor therapy 2001–2012 | |||||||
All patients, % (N = 5347) | |||||||
MAP < 80 mmHg | 99.3 | 95.7 | 87.3 | 67.0 | 49.8 | 37.3 | 28.6 |
MAP < 75 mmHg | 98.7 | 91.0 | 77.4 | 51.1 | 34.1 | 23.4 | 16.7 |
MAP < 65 mmHg | 93.4 | 62.0 | 35.0 | 14.1 | 7.3 | 4.1 | 2.7 |
MAP < 60 mmHg | 83.7 | 36.0 | 15.2 | 5.3 | 2.6 | 1.5 | 0.9 |
MAP < 55 mmHg | 67.6 | 17.2 | 6.0 | 2.4 | 1.2 | 0.6 | 0.4 |
Continuous time below MAP threshold during vasopressor therapy 2001–2008 | |||||||
All patients, % (N = 3173) | |||||||
MAP < 80 mmHg | 99.1 | 95.1 | 86.4 | 67.0 | 50.4 | 38.3 | 29.6 |
MAP < 75 mmHg | 98.1 | 89.9 | 76.3 | 51.3 | 34.8 | 24.3 | 17.6 |
MAP < 65 mmHg | 92.1 | 60.7 | 35.0 | 15.0 | 8.0 | 4.6 | 2.9 |
MAP < 60 mmHg | 81.1 | 35.7 | 15.6 | 6.0 | 3.1 | 1.7 | 0.9 |
MAP < 55 mmHg | 64.5 | 17.8 | 6.6 | 2.8 | 1.3 | 0.7 | 0.4 |
Continuous time below MAP threshold during vasopressor therapy 2008–2012 | |||||||
All patients, % (N = 2174) | |||||||
MAP < 80 mmHg | 99.8 | 96.7 | 88.6 | 67.1 | 48.9 | 35.9 | 27.0 |
MAP < 75 mmHg | 99.4 | 92.5 | 79.0 | 50.8 | 32.9 | 22.2 | 15.3 |
MAP < 65 mmHg | 95.3 | 63.8 | 35.1 | 12.7 | 6.3 | 3.4 | 2.3 |
MAP < 60 mmHg | 87.4 | 36.7 | 14.6 | 4.3 | 1.9 | 1.2 | 0.9 |
MAP < 55 mmHg | 72.1 | 16.4 | 5.3 | 1.9 | 1.1 | 0.5 | 0.4 |